Navigation Links
Successful Disease Management Programs Can Play Role in Health Care Reform
Date:6/8/2009

medications of the same type; and
  • 40 percent decrease in the number of patients receiving an unusually high dosage of medication.

  • A separate study of Missouri Medicaid patients found a 43 percent decrease in hospital admissions for those whose physicians received an educational mailing versus a 1 percent decrease in those from a similar comparison group who did not yet receive a mailing.(6)

    For other state examples of patient care improvements and cost savings, visit www.lillyforbetterhealth.com. The program has run in 26 states, including Oklahoma, which began its BPM in 2004.

    "We call our BPM 'SoonerPSYCH' which stands for Prescription Solutions for Your Cognitive Health. Through the program, our partnership with Lilly and CNS has allowed us to target physicians with patient-specific information and education in the most efficient and effective manner. Physicians are able to know whether their patients are filling the prescriptions on time or not at all, and to see if other physicians are prescribing similar medications for the same patient. Having the information in hand provides an opportunity for the physician to educate the patient about the chronic nature of their condition and the importance of persistence, compliance and adherence to their prescribed medication regimen," said Nancy Nesser, J.D., Pharm. D. pharmacy director for the Oklahoma Health Care Authority's state SoonerCare program.

    Evidence suggests that 96 cents of every Medicare dollar and 83 cents of every Medicaid dollar are used to treat chronic diseases.(7) Disease management programs help patients with chronic diseases manage their condition and get the care they need. For more than seven years, Lilly has funded disease management programs in partnership with state Medicaid departments.

    '/>"/>
    SOURCE Eli Lilly and Company
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine news :

    1. Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Age Affects Her Chances of Successful Pregnancy from Egg Donation
    2. MDCT angiography leads to successful treatment of severely blocked arteries in the legs
    3. Niutang Sucralose Patent Litigation Successfully Concluded
    4. Seabrook House, Inc. Successful in Recession Due to the Acceptance of Most Insurances; Expands With New Hires Due to the Growth of the Company
    5. Mylan Announces Successful Matrix Delisting Offer
    6. Avastin Unsuccessful as Adjuvant Therapy in Setting of Stage II and III Colon Cancer but May Be Effective if Given for Longer Duration
    7. Cenegenics Poses Challenge to Obama for Successful Healthcare Reform
    8. National Federation of the Blind Congratulates NASA on Successful Mission
    9. The T SystemEV(R) Featured in Journal of Emergency Nursing Paper on Successful EDIS Implementation
    10. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligonucleotide Synthesis
    11. Domain Registration Corp Successfully Completes Reverse Merger
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Breaking Medicine Technology:Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Akorn Inc Announces Third Quarter 2009 Earnings Release and Conference Call Information 60113 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 1Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 2Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 3Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 4Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 5Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 6Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 7Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 8Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 9Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 10Reportlinker Adds Bioinformatics and Computational Biology 3A Bottlenecks and Options 14598 11Medivation to Host Conference Call at 8 3A30 a m Eastern Time Tomorrow to Discuss Partnering Plans for MDV3100 14596 1